苑东生物：获得艾拉莫德片药品注册证书

Core Viewpoint - Yuan Dong Biotech (688513) announced the approval of its subsidiary Chengdu Shuo De Pharmaceutical Co., Ltd. for the drug registration certificate of Elamomab tablets by the National Medical Products Administration [1] Company Summary - The active ingredient of Elamomab tablets is Elamomab, which is indicated for the treatment of active rheumatoid arthritis [1] - Elamomab tablets are classified as a Category B drug in the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalog (2024) [1]